About
Giftshed develops an AI-powered liquid biopsy platform that captures and analyzes ultra-rare circulating tumor cells from blood at single-cell resolution to guide personalized cancer therapy decisions.
Explore Giftshed's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.